Progredienzangst entlang der Überlebensspanne: Ergebnisse einer Befragung erwachsener Langzeit-Krebsüberlebender,Karger Kompass Onkologie

当前位置： X-MOL 学术 › Karger Kompass Onkol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Progredienzangst entlang der Überlebensspanne: Ergebnisse einer Befragung erwachsener Langzeit-Krebsüberlebender
Karger Kompass Onkologie Pub Date : 2021-02-04 , DOI: 10.1159/000514703
Dominik Fugmann , André Karger

Objective: Our study analysed fear of cancer recurrence (FoR) in long-term cancer survivors in relation to medical variables, depression, anxiety, and quality of life. Methods: We present data obtained from 1,002 cancer survivors (53% male, mean age = 68 years, 26% prostate cancer, 22% breast cancer) across all cancer types 5 (N = 660) and 10 (N = 342) years after diagnosis, who were recruited via a large Clinical Cancer Registry in Germany in a cross-sectional study. FoR, depression, and anxiety were measured using validated self-report questionnaires (12-item short version of the Fear of Progression Questionnaire [FoP-Q-SF], Patient Health Questionnaire-9 [PHQ-9[, and General Anxiety Disorder-7 [GAD-7]). Hierarchical regression models were carried out with FoR as dependent variable and time since diagnosis as control variable. Results: We found high FoR-values in 17% of the cancer survivors (FoP-Q-SF total score>33). FoR was higher in the 5-year cohort (P = .028, d = 0.153). Cancer survivors were most worried about the future of the family; they report being nervous prior to doctor’s appointment and being afraid of relying on strangers help. Higher FoR was related to female gender (Beta = .149, P<.001), younger age (Beta = -.103, P<.001), low social (Beta = -.129, P<.001) and emotional functioning (Beta = -.269, P<.001), received hormone therapy (P = .025, d = 0.056), and high anxiety levels (Beta = .227, P<.001). Conclusions: Even though FoR declines slightly over time, it is still a common mental health problem for long-term survivors even 10 years after cancer diagnosis. Since FoR is associated with reduced emotional and social quality of life, patients who are at greater risk of experiencing FoR must be identified and supported. Particularly at risk are younger women who received hormone therapy.

更新日期：2021-02-04

点击分享查看原文

点击收藏

阅读更多本刊最新论文

全部期刊列表>>